Table 1.

Number of newborns with significant and non-significant congenital heart disease, stratified according to follow-up period

CHD	Follow-up period
	<  1 month	1–6 months	6 months to 2 years	>  2 years
Significant
ASD			3	3
VSD			12	2
PDA			1	4
MR			1	1
AR			1	3
PS				3
Non-significant
VSD	2	11
PDA	31	4
MR	3	4
AR	2	4

CHD congenital heart disease, ASD atrial septal defect, VSD ventricular septal defect, PDA patent ductus arteriosus, MR mitral regurgitation, AR aortic regurgitation, PS pulmonary stenosis